EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France

BACKGROUND EQOFIX is a medicoeconomic study that analyzed the health‐related quality of life (HRQoL) and costs of care of the moderate and severe forms of hemophilia B, treated on demand or by prophylaxis with either plasma‐derived Factor IX (pdFIX) or recombinant FIX (rFIX). STUDY DESIGN AND METHOD...

Full description

Saved in:

Bibliographic Details
Published in:	Transfusion Vol. 55; no. 7; pp. 1787 - 1797
Main Authors:	Polack, Benoît, Calvez, Thierry, Chambost, Hervé, Rothschild, Chantal, Goudemand, Jenny, Claeyssens, Ségolène, Borel-Derlon, Annie, Bardoulat, Isabelle, Maurel, Frédérique, Woronoff-Lemsi, Marie-Christine
Format:	Journal Article
Language:	English
Published:	United States Blackwell Publishing Ltd 01.07.2015 Wiley Wiley Subscription Services, Inc
Subjects:	[INFO.INFO-BT]Computer Science [cs]/Biotechnology Adolescent Adult Child Cohort Studies Costs Costs and Cost Analysis Economics and Finance Factor IX Factor IX - administration & dosage Factor IX - economics Female France Hematology Hemophilia Hemophilia B Hemophilia B - drug therapy Hemophilia B - economics Hemorrhage Hemorrhage - economics Hemorrhage - prevention & control Human health and pathology Humanities and Social Sciences Humans Life Sciences Male Middle Aged Quality of Life Santé publique et épidémiologie France
ISSN:	0041-1132, 1537-2995, 1537-2995
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!